Spontaneous Retroperitoneal Hemorrhage in Dermatomyositis

Am J Med. 2021 Feb;134(2):e137-e138. doi: 10.1016/j.amjmed.2020.06.038. Epub 2020 Jul 29.

Authors

Steven Li Fraine¹, Diana Coman², Virginie Vallée Guignard³, Jean-Pascal Costa⁴

Affiliations

¹ Department of Medicine, University of Montreal, Montreal, Quebec, Canada. Electronic address: steven.lifraine@gmail.com.
² Department of Medicine, University of Montreal, Montreal, Quebec, Canada.
³ Department of Medicine, McGill University, Montreal, Quebec, Canada.
⁴ Department of Medicine, University of Montreal, Montreal, Quebec, Canada; Division of General Internal Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.

PMID: 32735853
DOI: 10.1016/j.amjmed.2020.06.038

No abstract available

Publication types

Case Reports

MeSH terms

Anti-Inflammatory Agents / administration & dosage
Anti-Inflammatory Agents / therapeutic use
Anticoagulants / adverse effects
Anticoagulants / therapeutic use
Dalteparin / adverse effects
Dalteparin / therapeutic use
Dermatomyositis / drug therapy
Dermatomyositis / etiology*
Female
Hemorrhage / etiology*
Hemorrhage / pathology*
Humans
Immunoglobulins, Intravenous / administration & dosage
Immunoglobulins, Intravenous / therapeutic use
Methylprednisolone / administration & dosage
Methylprednisolone / therapeutic use
Middle Aged
Retroperitoneal Space / pathology*

Substances

Anti-Inflammatory Agents
Anticoagulants
Immunoglobulins, Intravenous
Dalteparin
Methylprednisolone